- 1. NAD analog
- [ ] (UMLS (CSP) C0920599) =Nucleic Acid, Nucleoside, or Nucleotide
| - 10. Nadene
- (UMLS (HL7) C1699250) =Language =AmericanIndianAlaskaNativeLanguages;
=Thlinget;
AthapaskanEyak |
- 2. NAD kinase
- [ ] (UMLS (CSP) C0068337) =Amino Acid, Peptide, or Protein; Enzyme ;
=alcohol phosphotransferase;
| - 11. NADH analog
- [ ] (UMLS (CSP) C0920600) =Nucleic Acid, Nucleoside, or Nucleotide
|
- 3. NAD phosphate
- [nicotinamide adenine dinucleotide phosphate; a coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate; serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced ( NADPH). ( CSP )] (UMLS (CSP) C0027303) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=adenine nucleotide;
cofactor;
high energy compound;
nicotinamide ribotide | - 12. NADH oxidoreductase
- [ ] (UMLS (CSP) C0682753) =Amino Acid, Peptide, or Protein; Enzyme
|
- 4. NAD transhydrogenase
- [An enzyme present in the mitochondrial membrane of animals and in microorganisms. In the presence of energy (ATP) it catalyzes reversibly the reduction of NAD by NADPH to yield NADP and NADH. This reaction permits the utilization of the reducing properties of NADPH by the respiratory chain and in the reverse direction it allows the reduction of NADP for biosynthetic purposes. EC 1.6.1.1. ( MSH )] (UMLS (CSP) C0027307) =Amino Acid, Peptide, or Protein; Enzyme ;
=NAD(P)H oxidoreductase;
| - 13. NADOLOL
- [A non-selective beta-adrenergic antagonist with antihypertensive and antiarrhythmic activities. Nadolol competitively blocks beta-1 adrenergic receptors located in the heart and vascular smooth muscle, therefore inhibiting the effects of catecholamines, epinephrine, and norepinephrine. As a result, this agent produces negative inotropic and chronotropic effects. Nadolol exerts its antiarrhythmic effect via impairment of atrioventricular (AV) node conduction and reduction of sinus rate. In addition, nadolol blocks beta-2 adrenergic receptors located in the bronchiole smooth muscle resulting in vasoconstriction. Furthermore, beta-2 receptor blockage within the juxtaglomerular apparatus leads to the inhibition of renin production, as well as subsequent reduction in angiotensin II and aldosterone levels, thereby inhibiting angiotensin II and aldosterone dependent vasoconstriction and water retention. ( NCI )] (UMLS (NCI) C0027302) =Organic Chemical; Pharmacologic Substance ;
=Propanolamines;
[CV100] BETA-BLOCKERS/RELATED =NADOLOL 120 MG;
NADOLOL 20 MG;
NADOLOL 40 MG;
NADOLOL 80 MG;
NADOLOL 160 MG |
- 5. NAD(+) ADP ribosyltransferase
- [An enzyme that catalyze the transfer of ADP-RIBOSE from NAD+ to an amino acid residue in a specific protein substrate. This reaction is catalyzed by both mono(ADP-ribose) transferases as well as POLY(ADP-RIBOSE) POLYMERASES. When the term NAD+ ADP-Ribosyltransferase refers to EC 2.4.2.30 it is referring to POLY(ADP-RIBOSE) POLYMERASES. ( MSH )] (UMLS (CSP) C1138564) =Amino Acid, Peptide, or Protein; Enzyme
| - 14. NADPH cytochrome c2 reductase
- [ ] (UMLS (CSP) C0311682) =Amino Acid, Peptide, or Protein; Enzyme =NAD(P)H oxidoreductase;
|
- 6. NAD(H) analog
- [synthetic or natural compounds which resemble the coenzyme nicotinamide adenine dinucleotide in structure and/or function. ( CSP )] (UMLS (CSP) C0597009) =Nucleic Acid, Nucleoside, or Nucleotide =nucleotide analog;
| - 15. NADPH dehydrogenase
- [A flavoprotein that reversibly oxidizes NADPH to NADP and a reduced acceptor. EC 1.6.99.1. ( MSH )] (UMLS (CSP) C0027312) =Amino Acid, Peptide, or Protein; Enzyme
|
- 7. NAD(P)H Dehydrogenase, Quinone 1 Gene
- [This gene is involved in drug/xenobiotic metabolism, biosynthetic processes and the prevention of cellular oxidative stress. ( NCI )] (UMLS (NCI) C0919428) NQO1;
NQO1 Gene =Gene or Genome ;
| - 16. NADPH Dependent Diflavin Oxidoreductase 1
- [Broadly expressed by human NR1 Gene (FNR Family), 597-aa 67-kDa cytoplasmic NADPH-Dependent FMN and FAD Containing Oxidoreductase is an enzyme homologous to cytochrome P-450 reductase that binds FMN, FAD, and NADPH cofactors, reduces cytochrome c, and metabolizes electron acceptors doxorubicin, menadione, and potassium ferricyanide. NR1 shares 41 to 44% similarity with nitric oxide synthase-2, methionine synthase transferase, and P-450 reductase. It may play a role in metabolic activation of bioreductive anticancer drugs and other chemicals activated by 1-electron reduction. (NCI) ( NCI )] (UMLS (NCI) C1312754) NADPH-Dependent FMN and FAD Containing Oxidoreductase;
NDOR1;
NR1 =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 8. NAD(P)H oxidoreductase
- [A group of oxidoreductases that act on NADH or NADPH. In general, enzymes using NADH or NADPH to reduce a substrate are classified according to the reverse reaction, in which NAD+ or NADP+ is formally regarded as an acceptor. This subclass includes only those enzymes in which some other redox carrier is the acceptor. (Enzyme Nomenclature, 1992, p100) EC 1.6. ( MSH )] (UMLS (CSP) C0027298) =Amino Acid, Peptide, or Protein; Enzyme ;
=dehydrogenase;
=glutathione reductase;
NAD transhydrogenase;
nitrate reductase;
cytochrome b5 reductase;
FMN reductase;
NADPH cytochrome c2 reductase;
hydrogen peroxide generating oxidase | - 17. NADPH oxidase
- [A flavoprotein enzyme that catalyzes the univalent reduction of OXYGEN using NADPH as an electron donor to create SUPEROXIDE ANION. The enzyme is dependent on a variety of CYTOCHROMES. Defects in the production of superoxide ions by enzymes such as NADPH oxidase result in GRANULOMATOUS DISEASE, CHRONIC. ( MSH )] (UMLS (CSP) C0068355) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 9. NADE
- [Cloned by its ability to interact with the death domain of nerve growth factor receptor. Likely to be involved in nerve growth factor-mediated apoptosis. (from OMIM) ( NCI )] (UMLS (NCI) C1334944) Nerve Growth Factor Receptor Associated Protein 1;
Nerve Growth Factor Receptor-Associated Cell Death Executor;
NGFRAP1;
Ovarian Granulosa Cell Protein (13kD);
p75(NTR)-Associated Cell Death Executor =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 18. Nadroparin
- [A low molecular weight heparin (LMWH) composed of a heterogeneous mixture of sulfated polysaccharide glycosaminoglycan chains obtained by depolymerisation of porcine mucosal sodium heparin, extraction/purification and conversion to the calcium salt. Nadroparin binds to antithrombin III (ATIII) and inhibits the activity of activated factor X (factor Xa), thereby inhibiting the final common pathway of the coagulation cascade and preventing the formation of a cross-linked fibrin clot. ( NCI )] (UMLS (NCI) C0206232) =Carbohydrate; Pharmacologic Substance
|
home
